NDC 70510-2321

RADICAVA ORS

Edaravone

RADICAVA ORS is a Kit in the Human Prescription Drug category. It is labeled and distributed by Mitsubishi Tanabe Pharma America, Inc.. The primary component is .

Product ID70510-2321_26a8730f-518e-40d1-b695-536526c6a87b
NDC70510-2321
Product TypeHuman Prescription Drug
Proprietary NameRADICAVA ORS
Generic NameEdaravone
Dosage FormKit
Marketing Start Date2022-05-12
Marketing CategoryNDA /
Application NumberNDA215446
Labeler NameMitsubishi Tanabe Pharma America, Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70510-2321-2

2 CARTON in 1 CARTON (70510-2321-2) > 1 KIT in 1 CARTON (70510-2321-1) * 1 BOTTLE in 1 KIT (70510-2323-1) > 35 mL in 1 BOTTLE
Marketing Start Date2022-05-12
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "RADICAVA ORS" or generic name "Edaravone"

NDCBrand NameGeneric Name
70510-2321RADICAVA ORSEDARAVONE
70510-2322RADICAVA ORSEDARAVONE
70510-2171RADICAVAEDARAVONE
70510-2172RADICAVAedaravone

Trademark Results [RADICAVA ORS]

Mark Image

Registration | Serial
Company
Trademark
Application Date
RADICAVA ORS
RADICAVA ORS
90594021 not registered Live/Pending
Mitsubishi Tanabe Pharma Corporation
2021-03-22
RADICAVA ORS
RADICAVA ORS
79298102 not registered Live/Pending
Mitsubishi Tanabe Pharma Corporation
2020-09-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.